These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 33401721)
1. Depletion of Mitochondrial Components from Extracellular Vesicles Secreted from Astrocytes in a Mouse Model of Fragile X Syndrome. Ha BG; Heo JY; Jang YJ; Park TS; Choi JY; Jang WY; Jeong SJ Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401721 [TBL] [Abstract][Full Text] [Related]
2. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo. Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586 [TBL] [Abstract][Full Text] [Related]
3. Astrocyte-mediated disruption of ROS homeostasis in Fragile X mouse model. Vandenberg GG; Dawson NJ; Head A; Scott GR; Scott AL Neurochem Int; 2021 Jun; 146():105036. PubMed ID: 33785420 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial bioenergetics of astrocytes in Fragile X syndrome: new perspectives on culture conditions and sex effects. Vandenberg GG; Thotakura A; Scott AL Am J Physiol Cell Physiol; 2022 Feb; 322(2):C125-C135. PubMed ID: 34817267 [TBL] [Abstract][Full Text] [Related]
5. Dysregulated Purinergic Signalling in Fragile X Syndrome Cortical Astrocytes. Reynolds KE; Napier M; Fei F; Green K; Scott AL Neuromolecular Med; 2024 Sep; 26(1):36. PubMed ID: 39254908 [TBL] [Abstract][Full Text] [Related]
6. Aberrant mitochondrial bioenergetics in the cerebral cortex of the Fmr1 knockout mouse model of fragile X syndrome. D'Antoni S; de Bari L; Valenti D; Borro M; Bonaccorso CM; Simmaco M; Vacca RA; Catania MV Biol Chem; 2020 Mar; 401(4):497-503. PubMed ID: 31702995 [TBL] [Abstract][Full Text] [Related]
7. Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome. Jawaid S; Kidd GJ; Wang J; Swetlik C; Dutta R; Trapp BD Glia; 2018 Apr; 66(4):789-800. PubMed ID: 29274095 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome. Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918 [TBL] [Abstract][Full Text] [Related]
9. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Yuskaitis CJ; Beurel E; Jope RS Biochim Biophys Acta; 2010 Nov; 1802(11):1006-12. PubMed ID: 20600866 [TBL] [Abstract][Full Text] [Related]
10. Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome. Hodges JL; Yu X; Gilmore A; Bennett H; Tjia M; Perna JF; Chen CC; Li X; Lu J; Zuo Y Biol Psychiatry; 2017 Jul; 82(2):139-149. PubMed ID: 27865451 [TBL] [Abstract][Full Text] [Related]
11. Excessive astrocyte-derived neurotrophin-3 contributes to the abnormal neuronal dendritic development in a mouse model of fragile X syndrome. Yang Q; Feng B; Zhang K; Guo YY; Liu SB; Wu YM; Li XQ; Zhao MG PLoS Genet; 2012; 8(12):e1003172. PubMed ID: 23300470 [TBL] [Abstract][Full Text] [Related]
12. Astrocyte-mediated purinergic signaling is upregulated in a mouse model of Fragile X syndrome. Reynolds KE; Wong CR; Scott AL Glia; 2021 Jul; 69(7):1816-1832. PubMed ID: 33754385 [TBL] [Abstract][Full Text] [Related]
13. Developmental Emergence of Phenotypes in the Auditory Brainstem Nuclei of Rotschafer SE; Cramer KS eNeuro; 2017; 4(6):. PubMed ID: 29291238 [TBL] [Abstract][Full Text] [Related]
14. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9. Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818 [TBL] [Abstract][Full Text] [Related]
15. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome. Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888 [TBL] [Abstract][Full Text] [Related]
16. Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex. Arsenault J; Hooper AWM; Gholizadeh S; Kong T; Pacey LK; Koxhioni E; Niibori Y; Eubanks JH; Wang LY; Hampson DR Hum Mol Genet; 2021 Feb; 29(23):3744-3756. PubMed ID: 33084871 [TBL] [Abstract][Full Text] [Related]
17. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice. Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536 [TBL] [Abstract][Full Text] [Related]
18. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388 [TBL] [Abstract][Full Text] [Related]
19. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response. Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097 [TBL] [Abstract][Full Text] [Related]